Co-Founder and CEO
Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Ginkgo is a synthetic biology company headquartered in Boston, MA that programs cells for customers in the chemical, pharmaceutical, food and energy industries. The company recently raised over $930M in venture capital to expand their automated genetic engineering foundries and is the largest designer of synthetic DNA in the world. Ginkgo is valued at $4.5B and has been listed for the past three years on CNBC's Disruptor 50 List of fast-growing companies. Prior to Ginkgo, Jason received B.S. degrees in Chemical Engineering and Biology and a PhD in Biological Engineering all from MIT.